← Leaderboards
Michelle S Bradbury
Sloan-Kettering Inst Can Research
$7,087,200
Attributed
$11,510,591
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,834,392 · 8
By mechanism
U54$11,087,585 · 3
R01$7,896,247 · 3
R21$835,560 · 1
R13$15,000 · 1
Top collaborators
- Ulrich Wiesner20 shared
- Michael H. Overholtzer6 shared
- Abdelkrim K. Touijer4 shared
- Hooisweng Ow1 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Ulrich Wiesner$4,616,977
- Michael H. Overholtzer$11,387,854
- Jan Grimm$17,140,928
- Teresa J Porri$282,085
- Abdelkrim K. Touijer$456,703
Others in their field
Top investigators on “Nanoparticle”
- David Heimbrook · Leidos Biomedical Research, Inc.$67,480,937
- Ralph Weissleder · Massachusetts General Hospital$52,944,531
- Robert J Hamers · University Of Wisconsin-Madison$40,936,500
- Gang Bao · Georgia Institute Of Technology$28,866,343
- Barton F Haynes · Duke University$28,645,614
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
NanoparticleMalignant NeoplasmsParticleTranslationsDesignTumorMolecularPropertyBaseIn VivoSilicon DioxideMelanomaDetectionBiologicalPositron-Emission TomographyLeadIn VitroStagingPhenotypeFluorescenceMelanoma CellOpticsMetastatic MelanomaClinical Trials
Grant awards (35)
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles$317,911
R01 · FY2025 · CA · contact PI
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer$494,251
R01 · FY2024 · CA · contact PI
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer$550,839
R01 · FY2023 · CA · contact PI
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles$431,104
R01 · FY2023 · CA · contact PI
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer$64,250
R01 · FY2023 · CA · contact PI
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles$1
R01 · FY2023 · CA · contact PI
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer$635,854
R01 · FY2022 · CA · contact PI
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles$538,399
R01 · FY2022 · CA · contact PI
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer$637,054
R01 · FY2021 · CA · contact PI
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles$435,128
R01 · FY2021 · CA · contact PI
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer$658,454
R01 · FY2020 · CA · contact PI
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles$396,582
R01 · FY2020 · CA · contact PI
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.$1,664,540
U54 · FY2019 · CA · contact PI
Real-time Intraoperative Imaging of Cancer Biomarkers and Peripheral Nerves$508,478
U54 · FY2019 · CA · contact PI
Administrative Core$130,075
U54 · FY2019 · CA · contact PI
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.$1,595,317
U54 · FY2018 · CA · contact PI
Real-time Intraoperative Imaging of Cancer Biomarkers and Peripheral Nerves$429,092
U54 · FY2018 · CA · contact PI
Administrative Core$130,415
U54 · FY2018 · CA · contact PI
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.$1,604,099
U54 · FY2017 · CA · contact PI
Real-time Intraoperative Imaging of Cancer Biomarkers and Peripheral Nerves$435,236
U54 · FY2017 · CA · contact PI
Administrative Core$130,442
U54 · FY2017 · CA · contact PI
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.$1,791,702
U54 · FY2016 · CA · contact PI
Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective Ra$493,088
R01 · FY2016 · CA · contact PI
Real-time Intraoperative Imaging of Cancer Biomarkers and Peripheral Nerves$370,450
U54 · FY2016 · CA · contact PI
Administrative Core$144,951
U54 · FY2016 · CA · contact PI
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.$1,668,143
U54 · FY2015 · CA · contact PI
Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective Ra$504,474
R01 · FY2015 · CA · contact PI
Real-time Intraoperative Imaging of Cancer Biomarkers and Peripheral Nerves$326,769
U54 · FY2015 · CA · contact PI
Administrative Core$157,876
U54 · FY2015 · CA · contact PI
Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective Ra$549,873
R01 · FY2014 · CA · contact PI
Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective Ra$501,146
R01 · FY2013 · CA · contact PI
Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective Ra$687,839
R01 · FY2012 · CA · contact PI
MRI-PET Guided Stereotactic Biopsy of High Grade Gliomas$417,780
R21 · FY2010 · CA · contact PI
Molecular Neuroimaging Symposium$15,000
R13 · FY2010 · EB · contact PI
MRI-PET Guided Stereotactic Biopsy of High Grade Gliomas$417,780
R21 · FY2009 · CA · contact PI